Sign up for Table of Contents Alerts.
Email this page
Print this page
Perspectives
The Role of VHL in the Regulation of E-Cadherin: A New Connection in an Old Pathway
Ryan C. Russell and Michael Ohh
volume 6 | issue 1
1 January 2007Pages: 56 - 59
We now provide open access to journal articles published online for one year or more. This article may be downloaded at the following link:
Download PDF If the document does not open, please right-click on the link (control-click on a Macintosh) and select the option to save the file to disk.
The von Hippel-Lindau (VHL) protein is a critical regulator of the ubiquitous oxygen-sensing pathway. VHL is a component of an E3 ubiquitin ligase that targets the α subunit of hypoxia-inducible factor (HIFα) for ubiquitin-mediated destruction under normal oxygen tension. As a consequence of HIFα stabilization upon the functional loss of VHL, the cell constitutively upregulates the hypoxic program resulting in the inappropriate expression of genes responsible for global changes in angiogenesis, energy metabolism, and proliferation. The emerging evidence suggests that the inactivation of VHL-HIF pathway is critical for the development of clear-cell renal cell carcinoma (CC-RCC). Until recently, the downstream effector(s) of HIF responsible for the oncogenic transformation of renal epithelial cells remained largely unknown. This review highlights recent discoveries uncovering the transcriptional regulation of E-cadherin, a homophilic cell adhesion molecule with anti-invasive properties in numerous epithelial-derived cancers, via the VHL-HIF pathway.
Authors
Ryan C. Russell
University of Toronto; Toronto, Ontario, Canada
Michael Ohh
University of Toronto; Toronto, Ontario Canada
We now provide open access to journal articles published online for one year or more. This article may be downloaded at the following link:
Download PDF If the document does not open, please right-click on the link (control-click on a Macintosh) and select the option to save the file to disk.